CFDE Data Portal | Search CIBAR2

	Label	Description
	CIBAR2 Gene (Entity type)	ENSG00000153789 - CBY1 interacting BAR domain containing 2
	GSE120612 etoposide leukocyte 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 10 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135352 0 V 1 NAPABUCASIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE164521 0 V 1 NITRIC OXIDE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE154074 5 V 0 BLEOMYCIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE157960 0 V 3 PROGESTERONE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE140441 temozolomide stem cell 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE185200 GSE185202 L-13 Ali-BL 0 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS

CIBAR2

ENSG00000153789 - CBY1 interacting BAR domain containing 2

GSE120612 etoposide leukocyte 6 v 1 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 10 v 5 human dn

A Gene Set from LINCS

GSE48812 sulforaphane 2 v 5 human up

A Gene Set from LINCS

GSE135352 0 V 1 NAPABUCASIN HUMAN UP

A Gene Set from LINCS

GSE164521 0 V 1 NITRIC OXIDE MOUSE DN

A Gene Set from LINCS

GSE154074 5 V 0 BLEOMYCIN MOUSE DN

A Gene Set from LINCS

GSE157960 0 V 3 PROGESTERONE MOUSE DN

A Gene Set from LINCS

GSE140441 temozolomide stem cell 2 v 0 human up

A Gene Set from LINCS

GSE185200 GSE185202 L-13 Ali-BL 0 v 9 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.